PUBLISHER: KBV Research | PRODUCT CODE: 1534621
PUBLISHER: KBV Research | PRODUCT CODE: 1534621
LAMEA Human Insulin Market Size, Share & Trends Analysis Report By Indication, By Product Type (Pens, Syringes, and Others), By Type of Insulin, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031
The Latin America, Middle East and Africa Human Insulin Market would witness market growth of 5.5% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Human Insulin Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $451.8 million by 2031. The Argentina market is showcasing a CAGR of 6.4% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 4.8% during (2024 - 2031).
Technological advancements in biotechnology have significantly transformed the human insulin market, developing more effective and safer insulin analogs. These innovations have improved patient outcomes and driven market expansion by addressing some of the key limitations of traditional insulin therapies. Insulin analogs are modified insulin forms that mimic the body's natural insulin release patterns. Unlike regular the insulin, which has a standard action profile, insulin analogs can be engineered to have different onset times, peak activity periods, and durations of action. This enables the management of blood glucose levels to be more precise and adaptable.
Advances in genetic engineering and protein modification technologies have driven the development of these analogs. Scientists have developed molecules with enhanced pharmacokinetic properties by modifying the amino acid sequence of insulin, thereby improving their absorption, distribution, metabolism, and excretion profiles. These modifications have led to insulin analogs that are more effective in controlling blood glucose levels and offer a lower risk of adverse effects, such as hypoglycemia, a common and potentially dangerous side effect of insulin therapy.
The LAMEA region is witnessing significant growth in this insulin market, driven by improving healthcare access and rising diabetes prevalence. Diabetes has been on the rise at an alarming rate in Latin America, particularly in countries such as Brazil. As per the data provided in 2022 by the Pan American Health Organization, more than 30 million individuals in Brazil were 60 years of age or elderly, accounting for 13 percent of the country's total population. By 2030, this age group will comprise 24 percent of the Brazilian population or approximately 50 million individuals. This increase in the aging population has resulted in an increased number of diabetes cases, which has prompted a greater demand for insulin products. Through its Unified Health System (SUS), the Brazilian government has made concerted efforts to enhance healthcare infrastructure and expand access to essential medications. In addition, international aid programs and partnerships with organizations such as the World Health Organization (WHO) are facilitating the expansion of insulin availability to those in need and bridging the gaps in healthcare delivery. Therefore, the high prevalence of diabetes and risk factors across the region will support the regional market's growth.
Based on Indication, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes. Based on Product Type, the market is segmented into Pens, Syringes, and Others. Based on Type of Insulin, the market is segmented into Rapid-acting insulin, Short-acting insulin, Intermediate-acting insulin, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- MannKind Corporation
- Lupin Limited
- Sanofi S.A.
- Novo Nordisk A/S
- Eli Lilly And Company
- Medtronic PLC
- Biocon Limited
- Tonghua Dongbao Pharmaceutical Co., Ltd.
- Pfizer, Inc.
LAMEA Human Insulin Market Report Segmentation
By Indication
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
By Product Type
- Pens
- Syringes
- Others
By Type of Insulin
- Rapid-acting insulin
- Short-acting insulin
- Intermediate-acting insulin
- Others
By Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Online Providers
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Human Insulin Market, by Indication
- 1.4.2 LAMEA Human Insulin Market, by Product Type
- 1.4.3 LAMEA Human Insulin Market, by Type of Insulin
- 1.4.4 LAMEA Human Insulin Market, by Distribution Channel
- 1.4.5 LAMEA Human Insulin Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. LAMEA Human Insulin Market by Indication
- 4.1 LAMEA Type 1 Diabetes Market by Country
- 4.2 LAMEA Type 2 Diabetes Market by Country
- 4.3 LAMEA Gestational Diabetes Market by Country
Chapter 5. LAMEA Human Insulin Market by Product Type
- 5.1 LAMEA Pens Market by Country
- 5.2 LAMEA Syringes Market by Country
- 5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Human Insulin Market by Type of Insulin
- 6.1 LAMEA Rapid-acting insulin Market by Country
- 6.2 LAMEA Short-acting insulin Market by Country
- 6.3 LAMEA Intermediate-acting insulin Market by Country
- 6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Human Insulin Market by Distribution Channel
- 7.1 LAMEA Hospital Pharmacies Market by Country
- 7.2 LAMEA Drug Stores & Retail Pharmacies Market by Country
- 7.3 LAMEA Online Providers Market by Country
Chapter 8. LAMEA Human Insulin Market by Country
- 8.1 Brazil Human Insulin Market
- 8.1.1 Brazil Human Insulin Market by Indication
- 8.1.2 Brazil Human Insulin Market by Product Type
- 8.1.3 Brazil Human Insulin Market by Type of Insulin
- 8.1.4 Brazil Human Insulin Market by Distribution Channel
- 8.2 Argentina Human Insulin Market
- 8.2.1 Argentina Human Insulin Market by Indication
- 8.2.2 Argentina Human Insulin Market by Product Type
- 8.2.3 Argentina Human Insulin Market by Type of Insulin
- 8.2.4 Argentina Human Insulin Market by Distribution Channel
- 8.3 UAE Human Insulin Market
- 8.3.1 UAE Human Insulin Market by Indication
- 8.3.2 UAE Human Insulin Market by Product Type
- 8.3.3 UAE Human Insulin Market by Type of Insulin
- 8.3.4 UAE Human Insulin Market by Distribution Channel
- 8.4 Saudi Arabia Human Insulin Market
- 8.4.1 Saudi Arabia Human Insulin Market by Indication
- 8.4.2 Saudi Arabia Human Insulin Market by Product Type
- 8.4.3 Saudi Arabia Human Insulin Market by Type of Insulin
- 8.4.4 Saudi Arabia Human Insulin Market by Distribution Channel
- 8.5 South Africa Human Insulin Market
- 8.5.1 South Africa Human Insulin Market by Indication
- 8.5.2 South Africa Human Insulin Market by Product Type
- 8.5.3 South Africa Human Insulin Market by Type of Insulin
- 8.5.4 South Africa Human Insulin Market by Distribution Channel
- 8.6 Nigeria Human Insulin Market
- 8.6.1 Nigeria Human Insulin Market by Indication
- 8.6.2 Nigeria Human Insulin Market by Product Type
- 8.6.3 Nigeria Human Insulin Market by Type of Insulin
- 8.6.4 Nigeria Human Insulin Market by Distribution Channel
- 8.7 Rest of LAMEA Human Insulin Market
- 8.7.1 Rest of LAMEA Human Insulin Market by Indication
- 8.7.2 Rest of LAMEA Human Insulin Market by Product Type
- 8.7.3 Rest of LAMEA Human Insulin Market by Type of Insulin
- 8.7.4 Rest of LAMEA Human Insulin Market by Distribution Channel
Chapter 9. Company Profiles
- 9.1 Biocon Limited
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Research & Development Expenses
- 9.2 Tonghua Dongbao Pharmaceutical Co., Ltd.
- 9.2.1 Company Overview
- 9.3 Lupin Limited
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 SWOT Analysis
- 9.4 MannKind Corporation
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.5 Sanofi S.A.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 SWOT Analysis
- 9.6 Novo Nordisk A/S
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental & Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 SWOT Analysis
- 9.7 Medtronic PLC
- 9.7.1 Company overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
- 9.8 Eli Lilly And Company
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 SWOT Analysis
- 9.9 Pfizer, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional & Segmental Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 LAMEA Human Insulin Market, 2020 - 2023, USD Million
- TABLE 2 LAMEA Human Insulin Market, 2024 - 2031, USD Million
- TABLE 3 LAMEA Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 4 LAMEA Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 5 LAMEA Type 1 Diabetes Market by Country, 2020 - 2023, USD Million
- TABLE 6 LAMEA Type 1 Diabetes Market by Country, 2024 - 2031, USD Million
- TABLE 7 LAMEA Type 2 Diabetes Market by Country, 2020 - 2023, USD Million
- TABLE 8 LAMEA Type 2 Diabetes Market by Country, 2024 - 2031, USD Million
- TABLE 9 LAMEA Gestational Diabetes Market by Country, 2020 - 2023, USD Million
- TABLE 10 LAMEA Gestational Diabetes Market by Country, 2024 - 2031, USD Million
- TABLE 11 LAMEA Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 12 LAMEA Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 13 LAMEA Pens Market by Country, 2020 - 2023, USD Million
- TABLE 14 LAMEA Pens Market by Country, 2024 - 2031, USD Million
- TABLE 15 LAMEA Syringes Market by Country, 2020 - 2023, USD Million
- TABLE 16 LAMEA Syringes Market by Country, 2024 - 2031, USD Million
- TABLE 17 LAMEA Others Market by Country, 2020 - 2023, USD Million
- TABLE 18 LAMEA Others Market by Country, 2024 - 2031, USD Million
- TABLE 19 LAMEA Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 20 LAMEA Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 21 LAMEA Rapid-acting insulin Market by Country, 2020 - 2023, USD Million
- TABLE 22 LAMEA Rapid-acting insulin Market by Country, 2024 - 2031, USD Million
- TABLE 23 LAMEA Short-acting insulin Market by Country, 2020 - 2023, USD Million
- TABLE 24 LAMEA Short-acting insulin Market by Country, 2024 - 2031, USD Million
- TABLE 25 LAMEA Intermediate-acting insulin Market by Country, 2020 - 2023, USD Million
- TABLE 26 LAMEA Intermediate-acting insulin Market by Country, 2024 - 2031, USD Million
- TABLE 27 LAMEA Others Market by Country, 2020 - 2023, USD Million
- TABLE 28 LAMEA Others Market by Country, 2024 - 2031, USD Million
- TABLE 29 LAMEA Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 30 LAMEA Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 31 LAMEA Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
- TABLE 32 LAMEA Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
- TABLE 33 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2020 - 2023, USD Million
- TABLE 34 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2024 - 2031, USD Million
- TABLE 35 LAMEA Online Providers Market by Country, 2020 - 2023, USD Million
- TABLE 36 LAMEA Online Providers Market by Country, 2024 - 2031, USD Million
- TABLE 37 LAMEA Human Insulin Market by Country, 2020 - 2023, USD Million
- TABLE 38 LAMEA Human Insulin Market by Country, 2024 - 2031, USD Million
- TABLE 39 Brazil Human Insulin Market, 2020 - 2023, USD Million
- TABLE 40 Brazil Human Insulin Market, 2024 - 2031, USD Million
- TABLE 41 Brazil Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 42 Brazil Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 43 Brazil Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 44 Brazil Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 45 Brazil Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 46 Brazil Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 47 Brazil Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 48 Brazil Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 49 Argentina Human Insulin Market, 2020 - 2023, USD Million
- TABLE 50 Argentina Human Insulin Market, 2024 - 2031, USD Million
- TABLE 51 Argentina Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 52 Argentina Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 53 Argentina Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 54 Argentina Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 55 Argentina Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 56 Argentina Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 57 Argentina Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 58 Argentina Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 59 UAE Human Insulin Market, 2020 - 2023, USD Million
- TABLE 60 UAE Human Insulin Market, 2024 - 2031, USD Million
- TABLE 61 UAE Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 62 UAE Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 63 UAE Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 64 UAE Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 65 UAE Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 66 UAE Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 67 UAE Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 68 UAE Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 69 Saudi Arabia Human Insulin Market, 2020 - 2023, USD Million
- TABLE 70 Saudi Arabia Human Insulin Market, 2024 - 2031, USD Million
- TABLE 71 Saudi Arabia Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 72 Saudi Arabia Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 73 Saudi Arabia Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 74 Saudi Arabia Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 75 Saudi Arabia Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 76 Saudi Arabia Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 77 Saudi Arabia Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 78 Saudi Arabia Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 79 South Africa Human Insulin Market, 2020 - 2023, USD Million
- TABLE 80 South Africa Human Insulin Market, 2024 - 2031, USD Million
- TABLE 81 South Africa Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 82 South Africa Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 83 South Africa Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 84 South Africa Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 85 South Africa Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 86 South Africa Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 87 South Africa Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 88 South Africa Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 89 Nigeria Human Insulin Market, 2020 - 2023, USD Million
- TABLE 90 Nigeria Human Insulin Market, 2024 - 2031, USD Million
- TABLE 91 Nigeria Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 92 Nigeria Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 93 Nigeria Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 94 Nigeria Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 95 Nigeria Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 96 Nigeria Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 97 Nigeria Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 98 Nigeria Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 99 Rest of LAMEA Human Insulin Market, 2020 - 2023, USD Million
- TABLE 100 Rest of LAMEA Human Insulin Market, 2024 - 2031, USD Million
- TABLE 101 Rest of LAMEA Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 102 Rest of LAMEA Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 103 Rest of LAMEA Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 104 Rest of LAMEA Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 105 Rest of LAMEA Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 106 Rest of LAMEA Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 107 Rest of LAMEA Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 108 Rest of LAMEA Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 109 Key Information - Biocon Limited
- TABLE 110 Key Information - Tonghua Dongbao Pharmaceutical Co., Ltd.
- TABLE 111 Key Information - Lupin Limited
- TABLE 112 Key Information - MannKind Corporation
- TABLE 113 Key Information - Sanofi S.A.
- TABLE 114 Key Information - Novo Nordisk A/S
- TABLE 115 Key Information - Medtronic PLC
- TABLE 116 Key Information - Eli Lilly And Company
- TABLE 117 Key Information - Pfizer, Inc.
